v3.20.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 86,254 $ 173,016
Accounts receivable, net 99,972 94,242
Inventories 20,286 14,405
Prepaid assets 6,884 6,327
Other current assets 2,046 2,748
Total current assets 215,442 290,738
Property and equipment (net of accumulated depreciation of $74,441 and $68,809, respectively) 83,392 64,188
Operating lease right-of-use assets 49,084 26,492
Intangible assets, net 128,289 126,640
Goodwill 210,833 198,601
Restricted cash, non-current 38,738 0
Prepaid lease asset 3,316 0
Other assets 3,153 2,847
Total assets 732,247 709,506
Current liabilities    
Accounts payable 20,453 19,568
Accrued compensation 20,810 21,365
Accrued expenses and other liabilities 8,966 7,548
Short-term portion of financing obligations 4,941 5,432
Short-term portion of operating leases 4,505 3,381
Short-term portion of term loan 5,000 5,000
Pharma contract liability 2,974 1,610
Total current liabilities 67,649 63,904
Long-term liabilities    
Long-term portion of financing obligations 2,428 3,199
Long-term portion of operating leases 45,910 24,034
Long-term portion of term loan, net 90,605 91,829
Other long term liabilities 4,235 3,566
Deferred income tax liability, net 16,377 15,566
Total long-term liabilities 159,555 138,194
Total liabilities 227,204 202,098
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 105,396,057 and 104,781,236 shares issued and outstanding, respectively) 105 105
Additional paid-in capital 525,929 520,278
Accumulated other comprehensive loss (2,656) (1,618)
Accumulated deficit (18,335) (11,357)
Total stockholders’ equity 505,043 507,408
Total liabilities and stockholders' equity $ 732,247 $ 709,506

Source